A Closer Look: Health Care Fraud Investigations In Pharma Sector Take New Twists
Executive Summary
Purdue Frederick's plea agreement with the government over its OxyContin promotion sent ripples through the pharmaceutical industry
You may also be interested in...
After Decade Of Settlements And CIAs, Omnicare Faces Another DOJ Complaint
Government alleges Omnicare and its parent CVS Health filled thousands of invalid prescriptions to elderly and disabled individuals; suit follows nine settlements and two corporate integrity agreements since 2006.
The Era Of Billion Dollar Pharma Settlements
Abbott Laboratories is the third pharmaceutical company to reach a settlement with the Department of Justice in excess of $1 billion. A look at the deals struck since Eli Lilly began the billion dollar club in 2009 shows the activities the government is investigating and the level of liability that companies face.
FDA's Executive Responsibility Policy Could Sweep In Board Members
Add board members to the list of company executives who could be personally affected by FDA's plans to focus on responsible individuals in the corporations it takes to task as part of its enforcement mission.